DD133795A5 - Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen - Google Patents

Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen

Info

Publication number
DD133795A5
DD133795A5 DD7700201831A DD20183177A DD133795A5 DD 133795 A5 DD133795 A5 DD 133795A5 DD 7700201831 A DD7700201831 A DD 7700201831A DD 20183177 A DD20183177 A DD 20183177A DD 133795 A5 DD133795 A5 DD 133795A5
Authority
DD
German Democratic Republic
Prior art keywords
arylocothydro
pyrindines
preparation
Prior art date
Application number
DD7700201831A
Other languages
German (de)
English (en)
Inventor
Dennis M Zimmermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD133795A5 publication Critical patent/DD133795A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD7700201831A 1976-11-02 1977-11-02 Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen DD133795A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
DD133795A5 true DD133795A5 (de) 1979-01-24

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700201831A DD133795A5 (de) 1976-11-02 1977-11-02 Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen

Country Status (26)

Country Link
JP (1) JPS5356669A (xx)
AR (1) AR223454A1 (xx)
AT (1) ATA782177A (xx)
AU (1) AU513679B2 (xx)
BE (1) BE860314A (xx)
CA (1) CA1100136A (xx)
CS (1) CS211380B2 (xx)
DD (1) DD133795A5 (xx)
DE (1) DE2748466A1 (xx)
DK (1) DK485277A (xx)
ES (3) ES463784A1 (xx)
FR (1) FR2369267A1 (xx)
GB (1) GB1590155A (xx)
GR (1) GR70053B (xx)
HU (1) HU176231B (xx)
IE (1) IE45901B1 (xx)
IL (1) IL53236A0 (xx)
NL (1) NL7712053A (xx)
NZ (1) NZ185539A (xx)
PH (1) PH12590A (xx)
PL (3) PL108610B1 (xx)
PT (1) PT67194B (xx)
RO (3) RO77935A (xx)
SE (3) SE7712218L (xx)
SU (3) SU812174A3 (xx)
ZA (1) ZA776497B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT68934A (en) * 1977-12-27 1979-01-01 Lilly Co Eli Process for preparing 4a-aryl-octahydro-1h-2-pyrindines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
EP2595989B1 (en) 2010-05-06 2016-07-13 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
WO2012106499A1 (en) 2011-02-02 2012-08-09 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Also Published As

Publication number Publication date
SE7712218L (sv) 1978-05-03
ZA776497B (en) 1979-06-27
PT67194A (en) 1977-11-01
GB1590155A (en) 1981-05-28
DK485277A (da) 1978-05-03
DE2748466A1 (de) 1978-05-03
FR2369267B1 (xx) 1980-05-16
ES463783A1 (es) 1979-07-16
SU913941A3 (en) 1982-03-15
SE8103107L (sv) 1981-05-18
PL109690B1 (en) 1980-06-30
PL201885A1 (pl) 1978-12-04
FR2369267A1 (fr) 1978-05-26
PH12590A (en) 1979-06-27
JPS5356669A (en) 1978-05-23
CA1100136A (en) 1981-04-28
SU845777A3 (ru) 1981-07-07
IL53236A0 (en) 1977-12-30
IE45901B1 (en) 1982-12-29
NL7712053A (nl) 1978-05-05
PL108466B1 (en) 1980-04-30
PT67194B (en) 1979-03-23
AU513679B2 (en) 1980-12-18
BE860314A (fr) 1978-04-28
ATA782177A (de) 1981-10-15
PL108610B1 (en) 1980-04-30
HU176231B (en) 1981-01-28
ES463784A1 (es) 1978-06-16
GR70053B (xx) 1982-07-26
ES472276A1 (es) 1979-10-01
SU812174A3 (ru) 1981-03-07
AU3023577A (en) 1979-05-10
SE8103106L (sv) 1981-05-18
RO78300A (ro) 1982-04-12
CS211380B2 (en) 1982-02-26
RO77935A (ro) 1981-12-25
IE45901L (en) 1978-05-02
RO72900A (ro) 1981-11-04
NZ185539A (en) 1979-12-11
AR223454A1 (es) 1981-08-31

Similar Documents

Publication Publication Date Title
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
AT348509B (de) Verfahren zur herstellung von acylcyaniden
ATA706577A (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
DD131026A5 (de) Verfahren zur herstellung von methyldichlorphosphan
PT67048B (de) Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD134085A5 (de) Verfahren zur herstellung von halogenacylamiden
ATA312477A (de) Verfahren zur herstellung von cholecystokinin- -pancreozymin-octapeptidamid-sulfatester
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD129792A5 (de) Verfahren zur herstellung von 1-oxadethiacephalosporinen
DD130785A1 (de) Verfahren zur herstellung von 4-chlor-5-alkoxycarbonyl-2-methoxypyrimidinen